KDR and cancer: Few studies have reported the conjugation of active targeting molecules to PFC droplets such as aptamer32, folate33, 34 and anti-vascular endothelial growth factor receptor 2 antibody with magnetism-assisted targeting35 in order to direct them to cancer cells.